Predictors of successful outcome after adrenalectomy for primary aldosteronism

International Surgery

Volumn 97, Issue 2, 2012, Pages 104-111

  Wang, Wei ^a   Hu, WeiLie ^a   Zhang, XiaoMing ^a   Wang, BangQi ^a   Bin, Chen ^a   Huang, Hai ^b  

^a GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Adrenalectomy; CYP11B2; Primary aldosteronism; Resistant hypertension

Indexed keywords

ALDOSTERONE SYNTHASE;

ADENOMA; ADRENAL TUMOR; ADRENALECTOMY; ADULT; ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; DECISION SUPPORT SYSTEM; EVALUATION STUDY; FEMALE; FOLLOW UP; GENETIC MARKER; GENETICS; GENOTYPING TECHNIQUE; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; HYPOKALEMIA; LAPAROSCOPY; MALE; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREOPERATIVE PERIOD; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL; TREATMENT OUTCOME;

ADENOMA; ADRENAL GLAND NEOPLASMS; ADRENAL HYPERPLASIA, CONGENITAL; ADRENALECTOMY; ADULT; ALDOSTERONE SYNTHASE; DECISION SUPPORT TECHNIQUES; FEMALE; FOLLOW-UP STUDIES; GENETIC MARKERS; GENOTYPING TECHNIQUES; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; HYPOKALEMIA; LAPAROSCOPY; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREOPERATIVE PERIOD; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84871205515     PISSN: 00208868     EISSN: None     Source Type: Journal    
DOI: 10.9738/CC140.1     Document Type: Article

References (30)

1. Lim PO, Rodgers P, Cardale K, Watson AD, MacDonald TM. Potentially high prevalence of primary aldosteronism in a primary-care population. Lancet 1999;353(9146):40
2. Fardella CE, Mosso L, Gómez-Sánchez C, Cortés P, Soto J, Gómez L, et al. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 2000;85(5):1863-1867
3. Fogari R, Preti P, Zoppi A, Rinaldi A, Fogari E, Mugellini A. Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test. Hypertens Res 2007;30(2):111-117
4. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005;45(8):1243-1248
5. Fallo F, Veglio F, Bertello C, Sonino N, Della Mea P, Ermani M, et al. Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J Clin Endocrinol Metab 2006;91(2):454-459
6. Walz MK, Gwosdz R, Levin SL, Alesina PF, Suttorp AC, Metz KA, et al. Retroperitoneoscopic adrenalectomy in Conn's syndrome caused by adrenal adenomas or nodular hyperplasia. World J Surg 2008;32(5):847-853
7. Meyer A, Brabant G, Behrend M. Long-term follow-up after adrenalectomy for primary aldosteronism. World J Surg 2005;29(2):155-159
8. Nejatizadeh A, Kumar R, Stobdan T, Goyal AK, Gupta M, Tyagi S, et al. CYP11B2 gene haplotypes independently and in concurrence with aldosterone and aldosterone to renin ratio increase the risk of hypertension. Clin Biochem 2010; 43(1-2):136-141
9. van Rijn-Bikker PC, Mairuhu G, van Montfrans GA et al. Genetic factors are relevant and independent determinants of antihypertensive drug effects in a multiracial population. Am J Hypertens 2009;22(12):1295-1302
10. Isaji M, Mune T, Takada N, Yamamoto Y, Suwa T, Morita H, et al. Correlation between left ventricular mass and urinary sodium excretion in specific genotypes of CYP11B2. J Hypertens 2005;23(6):1149-1157
11. Strauch B, Petrák O, Zelinka T, Wichterle D, Holaj R, Kasalický M, et al. Adrenalectomy improves arterial stiffness in primary aldosteronism. Am J Hypertens 2008;21(10):1086- 1092
12. Tuck ML, Corry DB. Renal damage in primary aldosteronism: results of the PAPY study. Curr Hypertens Rep 2007;9(2): 87-89
13. Sywak M, Pasieka JL. Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism. Br J Surg 2002;89(12):1587-1593
14. Zarnegar R, Young WF Jr, Lee J, Sweet MP, Kebebew E, Farley DR, et al. The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma. Ann Surg 2008;247(3):511-518
15. Kim RM, Lee J, Soh EY. Predictors of resolution of hypertension after adrenalectomy in patients with aldosteroneproducing adenoma. J Korean Med Sci 2010;25(7):1041- 1044
16. Arlt W. A detour guide to the Endocrine Society Clinical Practice Guideline on case detection, diagnosis and treatment of patients with primary aldosteronism. Eur J Endocrinol 2010;162(3):435-438
17. Gockel I, Heintz A, Polta M, Junginger T. Long-term results of endoscopic adrenalectomy for Conn's syndrome. Am Surg 2007;73(2):174-180
18. Rossi GP. Diagnosis and treatment of primary aldosteronism. Endocrinol Metab Clin North Am 2011;40(2):313-332
19. Zarnegar R, Lee J, Brunaud L, Lindsay S, Kebebew E, Clark OH, et al. Good blood pressure control on antihypertensives, not only response to spironolactone, predicts improved outcome after adrenalectomy for aldosteronoma. Surgery 2007;142(6):921-929
20. Bassett MH, Zhang Y, Clyne C, White PC, Rainey WE. Differential regulation of aldosterone synthase and 11b-hydroxylase transcription by steroidogenic factor-1. J Mol Endocrinol 2002;28(2):125-135
21. Ye P, Nakamura Y, Lalli E, Rainey WE. Differential effects of high and low steroidogenic factor-1 expression on CYP11B2 expression and aldosterone production in adrenocortical cells. Endocrinology 2009;150(3):1303-1309
22. Proye CA, Mulliez EA, Carnaille BM, Lecomte-Houcke M, Decoulx M, Wémeau JL, et al. Essential hypertension: first reason for persistent hypertension after unilateral adrenalectomy for primary aldosteronism? Surgery 1998;124(6):1128- 1133
23. Celen O, O'Brien MJ, Melby JC, Beazley RM. Factors influencing outcome of surgery for primary aldosteronism. Arch Surg 1996;131(6):646-650
24. Rossi GP, Bolognesi M, Rizzoni D, Seccia TM, Piva A, Porteri E, et al. Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients. Hypertension 2008;51(5):1366-1371
25. Douma S, Petidis K, Doumas M, Papaefthimiou P, Triantafyllou A, Kartali N, et al. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet 2008;371(9628):1921-1926
26. Rossi GP, Pessina AC. Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma. J Hypertens 2009;27(3):656-657
27. Gaddam KK, Pimenta E, Husain S, Calhoun DA. Aldosterone and cardiovascular disease. Curr Probl Cardiol 2009;34(2):51-84
28. Zarnegar R, Bloom AI, Lee J, Kerlan RK Jr, Wilson MW, Laberge JM, et al. Is adrenal venous sampling necessary in all patients with hyperaldosteronism before adrenalectomy? J Vasc Interv Radiol 2008;19(1):66-71
29. Tan YY, Ogilvie JB, Triponez F, Caron NR, Kebebew EK, Clark OH, et al. Selective use of adrenal venous sampling in the lateralization of aldosterone-producing adenomas. World J Surg 2006;30(5):879-885
30. Toniato A, Bernante P, Rossi GP, Pelizzo MR. The role of adrenal venous sampling in the surgical management of primary aldosteronism. World J Surg 2006;30(4):624-627